Ketorolac-Associated Renal Complications
Patient Risk Factors
- The risk of acute renal failure is particularly elevated in patients with marginal baseline kidney function, such as those with sickle cell crisis, according to the American Medical Association 1, 2
- Patients ≥60 years of age require cautious use, as recommended by Praxis Medical Insights 3
- Those with compromised fluid status or pre-existing renal impairment are at increased risk, as noted by Praxis Medical Insights 2, 3
- Patients on concomitant nephrotoxic drugs should be monitored closely, as advised by Praxis Medical Insights 3
Monitoring and Dosage Recommendations
- When initiating ketorolac therapy, monitor baseline and periodic BUN and creatinine, as recommended by Praxis Medical Insights 3
- Limit treatment duration to ≤5 days to minimize renal complications, as advised by Praxis Medical Insights 3
- Use maximum daily dose of 120 mg in adults and avoid exceeding recommended dosing, as recommended by Praxis Medical Insights 3